文献速递中枢神经肿瘤放疗放疗物理与技术

用波谱MRI定义胶质母细胞瘤隐匿病变:对临床靶区勾画的启示

Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineation.
PubMed 文献 · Radiat Oncol · 2025-05-22

该研究纳入18例原发胶质母细胞瘤(pGBM)和19例复发胶质母细胞瘤(rGBM)患者,在放疗模拟定位时行波谱MRI(sMRI),以胆碱/N-乙酰天冬氨酸>2倍(Cho/NAA>2x)为高风险浸润体积。结果显示pGBM的常规大CTV多能覆盖该体积,而rGBM常用的小CTV扩展覆盖不足,提示较大CTV扩展或Cho/NAA>2x引导可能有益。

要点

  • pGBM的Cho/NAA>2x中位体积45.0 cc,大于增强T1的32.3 cc。
  • rGBM的Cho/NAA>2x中位体积58.9 cc,远大于增强T1的21.7 cc。
  • rGBM不做CTV扩展仅覆盖61%的高风险体积,10/15/20 mm扩展覆盖87%/94%/98%。

核心结论

  • sMRI的Cho/NAA>2x可界定胶质母细胞瘤高风险隐匿病变,且超出增强T1边界。
  • pGBM的常规大CTV扩展多能覆盖Cho/NAA>2x体积,rGBM常用小CTV扩展覆盖不佳。
  • 结果提示rGBM采用较大CTV扩展或以Cho/NAA>2x引导可能有益。

研究设计与样本

  • 研究纳入pGBM 18例和rGBM 19例,均行sMRI与放疗模拟定位。
  • 勾画增强T1(T1PC)与T2/FLAIR体积,sMRI生成Cho/NAA>2x体积。
  • 计算Hausdorff距离以确定覆盖Cho/NAA>2x所需边缘,并在rGBM模拟不同CTV扩展的覆盖率。

主要发现

  • pGBM中位T1PC、Cho/NAA>2x、T2/FLAIR体积分别为32.3 cc、45.0 cc、74.8 cc。
  • rGBM中位T1PC、Cho/NAA>2x、T2/FLAIR体积分别为21.7 cc、58.9 cc、118.3 cc。
  • rGBM的T2/FLAIR相对T1PC体积增加比pGBM更明显(p ≤ 0.001)。
  • T1PC与Cho/NAA>2x间中位Hausdorff距离在pGBM为22.9 mm、rGBM为25.7 mm,提示高风险体积无明显变化。
  • rGBM不做CTV扩展仅覆盖61%的Cho/NAA>2x体积,10/15/20 mm扩展分别覆盖87%/94%/98%。

关键数值与推荐

  • 高风险隐匿病变定义为sMRI的Cho/NAA>2x体积。
  • rGBM常用不做CTV扩展时仅覆盖61%的Cho/NAA>2x体积。
  • rGBM的T1PC扩展10 mm覆盖87%、15 mm覆盖94%、20 mm覆盖98%的Cho/NAA>2x体积。

临床怎么用

  • sMRI的Cho/NAA>2x可用于识别超出增强T1的胶质母细胞瘤高风险隐匿病变。
  • rGBM勾画CTV时需注意小扩展可能覆盖不足,较大扩展或Cho/NAA>2x引导可能有益。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Outcomes in glioblastoma are improved by surgical resection and adjuvant radiation (RT). In primary GBM (pGBM), large clinical target volume (CTV) margins typically cover occult invasion. In recurrent GBM (rGBM), RT often uses tiny CTV margins that likely omit occult invasion due to re-RT radiation necrosis concerns. Whole-brain spectroscopic MRI (sMRI) is an emerging technique with similar resolution to PET that may help define the CTV for rGBM. METHODS: Patients with pGBM (n = 18) and rGBM (n = 19) underwent sMRI with RT simulation. T1-post contrast (T1PC) and T2/FLAIR MRI volumes were contoured. sMRI generated choline/N-acetylaspartate > 2x (Cho/NAA > 2x) volumes are known to correlate with high-risk invasion. Hausdorff distances were calculated to define the margin necessary to cover Cho/NAA > 2x in pGBM and rGBM. In rGBM, mock CTV expansions from T1PC volumes were created to determine non-selective CTV expansion sizes needed to cover Cho/NAA > 2x volumes. RESULTS: For pGBM, the median T1PC, Cho/NAA > 2x, and T2/FLAIR volumes were 32.3 cc, 45.0 cc, and 74.8 cc respectively. For rGBM, the median T1PC, Cho/NAA > 2x, and T2/FLAIR volumes were 21.7 cc, 58.9 cc, and 118.3 cc, respectively. T2/FLAIR volumes increased more relative to T1PC volumes in rGBM than pGBM (p ≤ 0.001). Meanwhile, the median Hausdorff distance between T1PC and Cho/NAA > 2x was 22.9 mm in pGBM and 25.7 mm in rGBM, suggesting that the high-risk volume does not significantly change. In rGBM, it is common to use no CTV expansion from the T1PC volume which only included 61% of high-risk Cho/NAA > 2x volume. Conversely, T1PC expansions of 10-, 15-, and 20-mm covered 87%, 94%, and 98% of Cho/NAA > 2x volume. CONCLUSIONS: sMRI Cho/NAA > 2x delineates high-risk occult disease in glioblastoma and extends beyond T1PC MRI borders. Typical large CTV expansions in pGBM mostly include Cho/NAA > 2x volumes. However, small CTV expansions commonly used in rGBM poorly cover Cho/NAA > 2x, suggesting that larger CTV expansions or Cho/NAA > 2x guidance may be of benefit.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Bell JB, Sheriff S, Goryawala MZ, et al. Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineation. Radiat Oncol. 2025. PMID: 40405247. doi:10.1186/s13014-025-02666-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。